Anixa Biosciences, Inc.ANIXNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank33
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-11.03M
Near historical average
Percentile
P33
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-11.22M
Historical baseline
PeriodValueYoY Change
TTM$-11.03M+5.7%
2025$-11.70M+7.6%
2024$-12.66M-15.5%
2023$-10.96M+20.1%
2022$-13.73M-5.0%
2021$-13.08M-30.8%
2020$-10.00M+9.1%
2019$-11.00M+20.8%
2018$-13.90M-235.7%
2017$-4.14M-